Related references
Note: Only part of the references are listed.Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis
Richard K. Burt et al.
JOURNAL OF NEUROLOGY (2022)
Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Tobias Alexander et al.
BONE MARROW TRANSPLANTATION (2022)
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
Basil Sharrack et al.
BONE MARROW TRANSPLANTATION (2020)
Effect of autologous hematopoietic stem cell transplantation on multiple sclerosis and neuromyelitis optica spectrum disorder: a PRISMA-compliant meta-analysis
Pengcheng Zhang et al.
BONE MARROW TRANSPLANTATION (2020)
Health economics and patient outcomes of hematopoietic stem cell transplantation versus disease-modifying therapies for relapsing remitting multiple sclerosis in the United States of America
Richard K. Burt et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation
Jeffrey A. Cohen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a Review of Current Literature and Future Directions for Transplant Haematologists and Oncologists
Joyutpal Das et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
Immune reconstitution therapies: concepts for durable remission in multiple sclerosis
Jan D. Lünemann et al.
Nature Reviews Neurology (2019)
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis A Randomized Clinical Trial
Richard K. Burt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Efficacy and safety of autologous hematopoietic stem-cell transplantation in multiple sclerosis: a systematic review and meta-analysis
Fangfang Ge et al.
NEUROLOGICAL SCIENCES (2019)
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos et al.
LANCET (2018)
Disease-modifying therapies for multiple sclerosis
Floriana De Angelis et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
Paolo A. Muraro et al.
NATURE REVIEWS NEUROLOGY (2017)
Autologous hematopoietic stem cell transplantation in multiple sclerosis A meta-analysis
Maria Pia Sormani et al.
NEUROLOGY (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial
Harold L. Atkins et al.
LANCET (2016)
Autologous hematopoietic stem cell transplantation in multiple sclerosis A phase II trial
Giovanni L. Mancardi et al.
NEUROLOGY (2015)
Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database
I. S. Mackenzie et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
A tutorial on sensitivity analyses in clinical trials: the what, why, when and how
Lehana Thabane et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis
P. Tappenden et al.
BONE MARROW TRANSPLANTATION (2010)
Share Paper
